Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Watchlist
Price: 36.2 NZD 0.36% Market Closed
Market Cap: 21.2B NZD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Intrinsic Value

The intrinsic value of one FPH stock under the Base Case scenario is 23.1 NZD. Compared to the current market price of 36.2 NZD, Fisher & Paykel Healthcare Corporation Ltd is Overvalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FPH Intrinsic Value
23.1 NZD
Overvaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Fisher & Paykel Healthcare Corporation Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for FPH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about FPH?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Fisher & Paykel Healthcare Corporation Ltd

Provide an overview of the primary business activities
of Fisher & Paykel Healthcare Corporation Ltd.

What unique competitive advantages
does Fisher & Paykel Healthcare Corporation Ltd hold over its rivals?

What risks and challenges
does Fisher & Paykel Healthcare Corporation Ltd face in the near future?

Summarize the latest earnings call
of Fisher & Paykel Healthcare Corporation Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fisher & Paykel Healthcare Corporation Ltd.

Provide P/S
for Fisher & Paykel Healthcare Corporation Ltd.

Provide P/E
for Fisher & Paykel Healthcare Corporation Ltd.

Provide P/OCF
for Fisher & Paykel Healthcare Corporation Ltd.

Provide P/FCFE
for Fisher & Paykel Healthcare Corporation Ltd.

Provide P/B
for Fisher & Paykel Healthcare Corporation Ltd.

Provide EV/S
for Fisher & Paykel Healthcare Corporation Ltd.

Provide EV/GP
for Fisher & Paykel Healthcare Corporation Ltd.

Provide EV/EBITDA
for Fisher & Paykel Healthcare Corporation Ltd.

Provide EV/EBIT
for Fisher & Paykel Healthcare Corporation Ltd.

Provide EV/OCF
for Fisher & Paykel Healthcare Corporation Ltd.

Provide EV/FCFF
for Fisher & Paykel Healthcare Corporation Ltd.

Provide EV/IC
for Fisher & Paykel Healthcare Corporation Ltd.

Show me price targets
for Fisher & Paykel Healthcare Corporation Ltd made by professional analysts.

What are the Revenue projections
for Fisher & Paykel Healthcare Corporation Ltd?

How accurate were the past Revenue estimates
for Fisher & Paykel Healthcare Corporation Ltd?

What are the Net Income projections
for Fisher & Paykel Healthcare Corporation Ltd?

How accurate were the past Net Income estimates
for Fisher & Paykel Healthcare Corporation Ltd?

What are the EPS projections
for Fisher & Paykel Healthcare Corporation Ltd?

How accurate were the past EPS estimates
for Fisher & Paykel Healthcare Corporation Ltd?

What are the EBIT projections
for Fisher & Paykel Healthcare Corporation Ltd?

How accurate were the past EBIT estimates
for Fisher & Paykel Healthcare Corporation Ltd?

Compare the revenue forecasts
for Fisher & Paykel Healthcare Corporation Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fisher & Paykel Healthcare Corporation Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fisher & Paykel Healthcare Corporation Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fisher & Paykel Healthcare Corporation Ltd compared to its peers.

Compare the P/E ratios
of Fisher & Paykel Healthcare Corporation Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Fisher & Paykel Healthcare Corporation Ltd with its peers.

Analyze the financial leverage
of Fisher & Paykel Healthcare Corporation Ltd compared to its main competitors.

Show all profitability ratios
for Fisher & Paykel Healthcare Corporation Ltd.

Provide ROE
for Fisher & Paykel Healthcare Corporation Ltd.

Provide ROA
for Fisher & Paykel Healthcare Corporation Ltd.

Provide ROIC
for Fisher & Paykel Healthcare Corporation Ltd.

Provide ROCE
for Fisher & Paykel Healthcare Corporation Ltd.

Provide Gross Margin
for Fisher & Paykel Healthcare Corporation Ltd.

Provide Operating Margin
for Fisher & Paykel Healthcare Corporation Ltd.

Provide Net Margin
for Fisher & Paykel Healthcare Corporation Ltd.

Provide FCF Margin
for Fisher & Paykel Healthcare Corporation Ltd.

Show all solvency ratios
for Fisher & Paykel Healthcare Corporation Ltd.

Provide D/E Ratio
for Fisher & Paykel Healthcare Corporation Ltd.

Provide D/A Ratio
for Fisher & Paykel Healthcare Corporation Ltd.

Provide Interest Coverage Ratio
for Fisher & Paykel Healthcare Corporation Ltd.

Provide Altman Z-Score Ratio
for Fisher & Paykel Healthcare Corporation Ltd.

Provide Quick Ratio
for Fisher & Paykel Healthcare Corporation Ltd.

Provide Current Ratio
for Fisher & Paykel Healthcare Corporation Ltd.

Provide Cash Ratio
for Fisher & Paykel Healthcare Corporation Ltd.

What is the historical Revenue growth
over the last 5 years for Fisher & Paykel Healthcare Corporation Ltd?

What is the historical Net Income growth
over the last 5 years for Fisher & Paykel Healthcare Corporation Ltd?

What is the current Free Cash Flow
of Fisher & Paykel Healthcare Corporation Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fisher & Paykel Healthcare Corporation Ltd.

Business Breakdown

Fisher & Paykel Healthcare Corporation Ltd., a leading provider of innovative medical devices and respiratory products, has carved a prominent niche in the global healthcare market. Founded in New Zealand in 1934, the company has evolved from a humble appliance manufacturer into a key player in respiratory care and sleep medicine. With a mission centered on improving patient outcomes, Fisher & Paykel leverages its strong research and development capabilities to create state-of-the-art products, such as its award-winning humidifiers and nasal mask systems, designed to support patients with respiratory issues and obstructive sleep apnea. The company boasts a diverse international presence, wit...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fisher & Paykel Healthcare Corporation Ltd

Current Assets 704.9m
Cash & Short-Term Investments 82m
Receivables 266.2m
Other Current Assets 356.7m
Non-Current Assets 1.6B
PP&E 1.3B
Intangibles 88.4m
Other Non-Current Assets 148.4m
Current Liabilities 385m
Accounts Payable 219.9m
Other Current Liabilities 165.1m
Non-Current Liabilities 137.6m
Long-Term Debt 92.9m
Other Non-Current Liabilities 44.7m
Efficiency

Earnings Waterfall
Fisher & Paykel Healthcare Corporation Ltd

Revenue
1.7B NZD
Cost of Revenue
-698.4m NZD
Gross Profit
1B NZD
Operating Expenses
-691m NZD
Operating Income
353.4m NZD
Other Expenses
-220.8m NZD
Net Income
132.6m NZD

Free Cash Flow Analysis
Fisher & Paykel Healthcare Corporation Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

FPH Profitability Score
Profitability Due Diligence

Fisher & Paykel Healthcare Corporation Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Operating Income
58/100
Profitability
Score

Fisher & Paykel Healthcare Corporation Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

FPH Solvency Score
Solvency Due Diligence

Fisher & Paykel Healthcare Corporation Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
64/100
Solvency
Score

Fisher & Paykel Healthcare Corporation Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FPH Price Targets Summary
Fisher & Paykel Healthcare Corporation Ltd

Wall Street analysts forecast FPH stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FPH is 34.06 NZD with a low forecast of 26.26 NZD and a high forecast of 41.16 NZD.

Lowest
Price Target
26.26 NZD
27% Downside
Average
Price Target
34.06 NZD
6% Downside
Highest
Price Target
41.16 NZD
14% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for FPH?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for FPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd

Country

New Zealand

Industry

Health Care

Market Cap

21.1B NZD

Dividend Yield

1.15%

Description

Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The firm offers its products across hospital and homecare settings. The Company’s hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include the Company’s continuous positive airway pressure (CPAP) therapy masks, as well as flow generators, interfaces, and data management technologies. The firm operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, Germany, Austria, Italy, Turkey, China, Hong Kong, Taiwan, Malaysia, Singapore and Australia.

Contact

AUCKLAND
15 Maurice Paykel Place, East Tamaki
+6495740100.0
www.fphcare.com

IPO

2001-11-13

Employees

7 375

Officers

MD, CEO & Executive Director
Mr. Lewis G. Gradon
Chief Financial Officer
Ms. Lyndal York
COO & GM of Respiratory Humidification
Mr. Andy Niccol
Vice President of Products & Technology
Dr. Andrew Somervell
Head of Capital Markets & Investor Relations
Hayden Brown
Company Secretary & General Counsel
Raelene Leonard
Show More
Senior Communications & Investor Relations Manager
Daniel Adolph
VP of Sales & Marketing and President of North America & Europe
Mr. Justin Callahan
Vice President of Human Resources
Ms. Nicola Talbot
Vice President of Supply Chain, Facilities & Sustainability
Mr. Jonathan Rhodes
Show Less

See Also

Discover More
What is the Intrinsic Value of one FPH stock?

The intrinsic value of one FPH stock under the Base Case scenario is 23.1 NZD.

Is FPH stock undervalued or overvalued?

Compared to the current market price of 36.2 NZD, Fisher & Paykel Healthcare Corporation Ltd is Overvalued by 36%.

Back to Top